Nanogen, Inc. (NGEN) Announces Collaboration with Canadian Agencies to Develop Veterinary and Bioterror Diagnostics  
6/12/2007 12:31:08 PM

SAN DIEGO--(BUSINESS WIRE)--Nanogen, Inc. (Nasdaq:NGEN), developer of advanced diagnostic products, announced today that it has received project funding from several Canadian agencies, including the Canadian Food Inspection Agency (CFIA). The purpose of the funding and collaborative agreement is to develop diagnostic tools for the detection of natural or potential bioterror threats to livestock, such as foot and mouth disease and avian flu, employing the company’s NanoChip® platform.